Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Critics Of Thailand’s Universal Healthcare Revamp Say $1 Is Too Much To Pay

This article was originally published in PharmAsia News

Executive Summary

Thailand’s universal healthcare system proposal would see those not covered under civil servant and employee coverage paying about $1 for treatment, and critics say the fee is too high.

You may also be interested in...



Thailand's Cost Control Measures And What They Mean For Pharma - IMS Analysis

SHANGHAI - Thailand's recent clampdown on public healthcare spending means multinational drug makers will have to look for news ways to tap the country's drug market, according to IMS Health

Sanofi Asks Thailand To Review Compulsory Licensing Policy

Sanofi-Aventis sent a request to the previous Thai Minister of Commerce Mingkwan Sangsuwan to review the process of compulsory licensing on patented drugs, Graham Almond, Sanofi-Aventis Thailand general manager told PharmAsia News.

Thai Officials Say Compulsory Licenses Will Not Deter Biotech Business – BIO 2008 Exclusive

SAN DIEGO - Industry furor over Thailand's compulsory license position will not deter multinational companies from investing in the country, according to Thai officials who sat down with PharmAsia News during the BIO 2008 convention in San Diego

Topics

Related Companies

UsernamePublicRestriction

Register

ID1131516

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel